Comparative study of the immunohistochemical expression of metalloproteinases 2, 7 and 9 between clearly invasive carcinomas and "in situ" trophoblast invasion

Neoplasma

Volumn 57, Issue 1, 2010, Pages 20-28

  Ioannidis, I ^a   Dimo, B ^a   Karameris, A ^a   Vilaras, G ^a   Gakiopoulou, H ^b   Patsouris, E ^b   Lazaris, A C ^b  

^a 417 NIMTS Veterans Hospital   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Invasive carcinomas; Metalloproteinases; Trophoblast invasion

Indexed keywords

GELATINASE A; GELATINASE B; MATRILYSIN; METALLOPROTEINASE; MMP7 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER INVASION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DECIDUA; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INVASIVE CARCINOMA; KIDNEY CARCINOMA; LUNG CARCINOMA; PROTEIN EXPRESSION; STOMACH CARCINOMA; STROMA CELL; TROPHOBLAST; COMPARATIVE STUDY; ENZYMOLOGY; NEOPLASM; PHYSIOLOGY; PREGNANCY;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; METALLOPROTEASES; NEOPLASMS; PREGNANCY; TRANSFORMING GROWTH FACTOR BETA; TROPHOBLASTS;

EID: 77953640204     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: 10.4149/neo_2010_01_020     Document Type: Article

References (29)

1. WANG H, WEN Y, MOONEY S, LI H, BEHR B, POLAN M, Matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase expression in human preimplantation embryos. Fertility and sterility 2003; 80: 736-742 doi:10.1016/S0015-0282(03)00782-9
2. BJORN F. S, HASTRUP N, LUND R. F, DANO K, LARSEN F. et al. Co-ordinate expression of MMP-2 and its putative activator, MT1-MMP, in human placentation. Mol Hum Reprod 1997; 3: 713-723 doi:10.1093/molehr/3.8.713
3. BISCHOF P, MARTELLI M, CAMPANA A, ITOH Y, OGATA Y, NAGASE H. Importance of metallo-proteinases (MMP) in human trophoblastic invasion. Early Pregnancy 1995; 1: 263-9.
4. EGEBLAD M, WERB Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74 doi:10.1038/nrc745
5. OVERALL CM, KLEIFELD O. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2002; 2: 657-72 doi:10.1038/nrc884
6. FOLGUERAS AR. PENDAS AM, SANCHEZ LM, LOPEZOTIN C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 2004; 48: 411-24 doi:10.1387/ijdb.041811af
7. CURRAN S, MURRAY GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000; 36: 1621-1630 doi:10.1016/ S0959-8049(00)00156-8
8. LAMBERT V, WIELOCKX B, MUNAUT C, GALOPIN C, JOST M, et al. MMP2 and MMP9 synergize in promoting choroidal neurovascularization. FASEB J 2003; 17: 2290-2
9. MASSON V, DE LA BALLINA LR, MUNAUT C, WIELOCKX B, JOST M, et al. Contribution of host MMP2 and MMP9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J 2005; 18: 234
10. JOHANSSON N, AHONEN M, KAHARI VM. Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 2000; 57: 5-15 doi:10.1007/s000180050495
11. TRUDEL D, FRADET Y, MEYER F, HAREL F, TETU B. Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunocytochemistry. Hum Pathol 2008; 39: 731-739 doi:10.1016/j.humpath.2007.09.021
12. GRAESSLIN O, CORTEZ A, FAUVET R, LORENZATO M, BIREMBAUT et al. Metalloproteinase-2,-7 and-9 and tissue inhibitor of metalloproteinase-1 and-2 expression in normal, hyperplastic and neoplastic endometrium: a clinicalpathological correlation study. Ann Oncol 2006; 17: 637-645. doi:10.1093/annonc/mdj129
13. MURRAY GI, DUNCAN ME, ARBUCKLE E, MELVIN WT. Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 1998; 43: 791-797
14. ZENG ZS, HUANG Y, COHEN AM, GUILLEM JG. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. J Clin Oncol 1996; 14: 3133-3140
15. LEINONEN, R. PIRINEN, J. BÖHM, R. JOHANSSON, K. ROPPONEN et al. Expression of matrix metalloproteinases 7 and 9 in non-small cell lung cancer. Relation to clinicopathological factors, β-catenin and prognosis. Lung Cancer 2006; 51: 313-321 doi:10.1016/j.lungcan.2005.11.002
16. IWATA H, KOBAYASHI S, IWASE H, MASAOKA A, et al. Production of metalloproteinase and tissue inhibitors of metalloproteinases in human breast carcinoma. Jpn J Cancer Res 1996; 87: 602-611.
17. XU P, WANG Y, ZHU S, LUO S, PIAO Y, et al. Expression of matrix metalloproteinase-2,-9 and-14, tissue inhibitors of metalloproteinase-1 and matrix proteins in human placenta during the first trimester. Biol Reprod 2000; 62, 988-994. doi:10.1095/biolreprod62.4.988
18. STAUN-RAM E, GOLDMAN S, GABARIN D, SHALEV E. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and-9) in human trophoblast invasion. Reprod Biol Endonicrinol 2004; 2: 59 doi:10.1186/1477-7827-2-59
19. FATA JE, HO A-V, LECO KJ, MOOREHEAD RA, KHOKHA R. Cellular turnover and extracellular matrix remodeling in female reproductive tissues:functions of metalloproteinases and their inhibitors. Cell Mol Life Sci 2000; 57: 77-95 doi:10.1007/s000180050500
20. NOEL A, MAUD J, MAQUOI E. Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol 2008; 19: 52-60 doi:10.1016/j.semcdb.2007.05.011
21. ITOH T, TANIOKA M, YOSHIDA H, YOSHIOKA T, NISHIMOTO H, et al. Reduced angiogenesis and tumor progression in gelatinase A deficient mice. Cancer Res 1998; 58: 1048-1051
22. BRAMHALL SR, NEOPTOLEMOS JR, STAMP GW, LEMOINE NR. Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinase (TIMPs) in human pancreatic carcinoma. J Pathol 1997; 182: 347-355 doi:10.1002/(SICI)1096-9896(199707)182:3<347:: AID-PATH848>3.0.CO;2-J
23. STEARNS ME, STEARNS M. Immunohistochemical studies of activated matrix metalloproteinase-2 (MMP-2a) expression in human prostate cancer. Oncol Res 1996; 8: 63-67.
24. SALAMONSEN A. Role of proteases in implantation. Rev Reprod 1999; 4: 11-doi:10.1530/ror.0.0040011
25. DECLERCK AY, MERCURIO MA, STACK MS, CHAPMAN AH, ZUTTER MM et al. Proteases, Extracellular Matrix, and Cancer. Am J Pathol 2004; 164: 1131-1139
26. CRUZ-MUNOZ W, KHOKHA R. The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis. CRC Crit Rev Clin Lab Sci 2008; 45: 291-338 doi:10.1080/ 10408360801973244
27. BERGERS G, BREKKEN R, MCMAHON G, VU TH, ITOH T et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2: 737-44 doi:10.1038/35036374
28. BATES RC, MERCURIO AM. Tumor necrosis factor-a stimulates the epithelial to mesenchymal transition of human colonic organoids. Mol Biol Cell 2003, 14: 1790-1800 doi:10.1091/mbc.E02-09-0583
29. FINGLETON B, VARGO-GOGOLA T, CRAWFORD HC, MATRISIAN LM. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. Neoplasia 2001, 3: 459-468 doi:10.1038/sj.neo.7900190